The natural history of end-stage knee osteoarthritis: Data from the osteoarthritis initiative

被引:8
作者
Driban, Jeffrey B. [1 ]
Price, Lori Lyn [2 ,3 ]
Lu, Bing [4 ]
Flechsenhar, Klaus [5 ]
Lo, Grace H. [6 ,7 ]
McAlindon, Timothy E. [1 ]
机构
[1] Tufts Med Ctr, Div Rheumatol Allergy & Immunol, 800 Washington St, POB 406, Boston, MA 02111 USA
[2] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA
[3] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA USA
[4] Univ Connecticut, Hlth Ctr, Dept Publ Hlth Sci, Farmington, CT USA
[5] Immunol & Inflammat Therapeut Area, Type 1-17 Immunol Cluster, Frankfurt, Germany
[6] Michael E DeBakey VAMC, Houston VA HSR &D Ctr Innovat Qual Effectiveness &, Med Care Line & Res Care Line, Houston, TX USA
[7] Baylor Coll Med, Sect Immunol Allergy & Rheumatol, Houston, TX USA
基金
美国国家卫生研究院;
关键词
Pain; Osteoarthritis; Knee; Patient -reported outcome measures; APPROPRIATENESS; ARTHROPLASTY; CRITERIA;
D O I
10.1016/j.semarthrit.2022.152148
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We aimed to describe the natural history leading to end-stage knee osteoarthritis (esKOA), focusing on knee symptoms, radiographic severity, and the presence of limited mobility or instability. Methods: We performed knee-based analyses of Osteoarthritis Initiative data from 7691 knees (4165 partici-pants). We used a validated definition of esKOA that relied on meeting one of two criteria: (1) severe radio-graphic knee osteoarthritis (Kellgren-Lawrence [KL] grade=4) with moderate-to-intense pain (Likert WOMAC pain+function>11/88) or (2) KL grade<4 with intense or severe pain (WOMAC pain+function>22) and limited mobility (flexion contracture >= 5 degrees) or instability (based on a varus and valgus stress test). We also introduced an alternate definition of esKOA that relied on meeting one of two criteria that omitted physical exam findings:(1) severe radiographic knee osteoarthritis (KL grade=4) with at least moderate symptoms or (2) KL grade=2 or 3 with intense or severe symptoms and persistent knee pain (frequent knee pain during three or more months in the past year). We used descriptive statistics to explore the frequency of components of esKOA at the index visit when they had incident esKOA, at the annual visit before developing esKOA, and the interval change between those visits. Results: Our analytic sample was mostly female (58%), without radiographic knee osteoarthritis (KL grade=0 or 1; 60%), without stability or mobility concerns (91%), and without persistent knee pain (77%). At the visit before incident esKOA, most knees already had moderate-to-severe radiographic osteoarthritis using the original (62%) or alternate (50%) definition (versus <15% for either definition of no esKOA). Over 80% of knees that reached the criteria for esKOA achieved this based on increased knee symptom severity - typically without worsening radiographic severity (80%).
引用
收藏
页数:8
相关论文
共 13 条
[1]  
[Anonymous], 2018, GUIDANCE IND OSTEOAR
[2]   Reliability of the knee examination in osteoarthritis - Effect of standardization [J].
Cibere, J ;
Bellamy, N ;
Thorne, A ;
Esdaile, JM ;
McGorm, KJ ;
Chalmers, A ;
Huang, S ;
Peloso, P ;
Shojania, K ;
Singer, J ;
Wong, H ;
Kopec, J .
ARTHRITIS AND RHEUMATISM, 2004, 50 (02) :458-468
[3]   Defining and evaluating a novel outcome measure representing end-stage knee osteoarthritis: data from the Osteoarthritis Initiative [J].
Driban, Jeffrey B. ;
Price, Lori Lyn ;
Lynch, John ;
Nevitt, Michael ;
Lo, Grace H. ;
Eaton, Charles B. ;
McAlindon, Timothy E. .
CLINICAL RHEUMATOLOGY, 2016, 35 (10) :2523-2530
[4]   Development of explicit criteria for total knee replacement [J].
Escobar, A ;
Quintana, JM ;
Aróstegui, I ;
Azkárate, J ;
Güenaga, JI ;
Arenaza, JC ;
Garai, I .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2003, 19 (01) :57-70
[5]  
Felson DT, 2008, J RHEUMATOL, V35, P2047
[6]   Sample size calculations for detecting disease-modifying osteoarthritis drug effects on the incidence of end-stage knee osteoarthritis in clinical trials: Data from the Osteoarthritis Initiative [J].
Flechsenhar, Klaus ;
Ried, Janina S. ;
Driban, Jeffrey B. ;
Price, Lori Lyn ;
McAlindon, Timothy .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 49 (01) :3-8
[7]   The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement [J].
Gossec, L. ;
Paternotte, S. ;
Maillefert, J. F. ;
Combescure, C. ;
Conaghan, P. G. ;
Davis, A. M. ;
Gunther, K. -P. ;
Hawker, G. ;
Hochberg, M. ;
Katz, J. N. ;
Kloppenburg, M. ;
Lim, K. ;
Lohmander, L. S. ;
Mahomed, N. N. ;
March, L. ;
Pavelka, K. ;
Punzi, L. ;
Roos, E. M. ;
Sanchez-Riera, L. ;
Singh, J. A. ;
Suarez-Almazor, M. E. ;
Dougados, M. .
OSTEOARTHRITIS AND CARTILAGE, 2011, 19 (02) :147-154
[8]   Perspectives of Canadian Stakeholders on Criteria for Appropriateness for Total Joint Arthroplasty in Patients With Hip and Knee Osteoarthritis [J].
Hawker, Gillian ;
Bohm, Eric R. ;
Conner-Spady, Barbara ;
De Coster, Carolyn ;
Dunbar, Michael ;
Hennigar, Allan ;
Loucks, Lynda ;
Marshall, Deborah A. ;
Pomey, Marie-Pascale ;
Sanmartin, Claudia ;
Noseworthy, Tom .
ARTHRITIS & RHEUMATOLOGY, 2015, 67 (07) :1806-1815
[9]   OARSI-FDA initiative: defining the disease state of osteoarthritis [J].
Lane, N. E. ;
Brandt, K. ;
Hawker, G. ;
Peeva, E. ;
Schreyer, E. ;
Tsuji, W. ;
Hochberg, M. C. .
OSTEOARTHRITIS AND CARTILAGE, 2011, 19 (05) :478-482
[10]  
OsteoArthritis Initiative Study Team, 2004, OAI